Cardiovascular

Gender bias in FDA premarket approval of cardiovascular devices

A systematic review of high-risk cardiovascular devices receiving premarket approval from the U.S. Food and Drug Administration (FDA) found that women were under-represented in the evidence presented to the FDA.  Read more at http://circoutcomes.ahajournals.org/content/early/2011/03/01/CIRCOUTCOMES.110.958215.abstract.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Test Your Nursing Knowledge

Answer this interactive quiz to be entered to win a gift card.

  • This field is for validation purposes and should be left unchanged.

Insights Blog

Today’s News in Nursing

Shares